China Deal Monitor: Kechow Pharma raises Series C and more updates

Shanghai Kechow Pharma, a small molecule drug development company, has raised 313 million yuan ($45 million) in its Series C round led by Decheng Capital, per a company statement. 

Qiming Venture Partners, Sherpa Capital, and existing investor Grains Valley Venture Capital also joined the round. Kechow has secured $60 million in rounds of financing since 2018. 

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief
Subscribe to Newsletter